Current and Future Treatments for Parathyroid Carcinoma
Author(s) -
Kristin L. Long,
Rebecca S. Sippel
Publication year - 2018
Publication title -
international journal of endocrine oncology
Language(s) - English
Resource type - Journals
eISSN - 2045-0877
pISSN - 2045-0869
DOI - 10.2217/ije-2017-0011
Subject(s) - medicine , parathyroid carcinoma , primary hyperparathyroidism , disease , adjuvant , carcinoma , hyperparathyroidism , intensive care medicine , radiology , surgery , general surgery , oncology
Parathyroid carcinoma (PC) is a rare disease and presents clinical challenges in diagnosis, management and adjuvant treatment. Rarely diagnosed preoperatively, PC is often discovered in the treatment of primary hyperparathyroidism. PC is predominantly treated surgically with minimal additional treatments available. Given the rarity of the disease, current and future efforts, as discussed in this article, are focused on increasing preoperative diagnosis, recognizing genetic patterns and pathologic markers and delineating nonsurgical options for patients with advanced disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom